| [1] |
郑荣寿，孙可馨，张思维，等.2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志， 2019，41(1): 19-28.
|
| [2] |
Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling [J]. J Biol Chem, 2001, 276(40): 36 869-36 872.
|
| [3] |
Carmeci C, Thompson DA, Ring HZ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer[J]. Genomics, 1997, 45(3): 607-617.
|
| [4] |
Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling [J]. Science, 2005, 307(5715): 1625-1630.
|
| [5] |
Thomas P, Pang Y, Filardo EJ, et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells[J]. Endocrinology, 2005, 146(2): 624-632.
|
| [6] |
Filardo E, Quinn J, Pang Y, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane[J]. Endocrinology, 2007, 148(7): 3236-3245.
|
| [7] |
Albanito L, Madeo A, Lappano R, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells[J]. Cancer Res, 2007, 67(4): 1859-1866.
|
| [8] |
Pupo M, Pisano A, Lappano R, et al. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts[J]. Environ Health Perspect, 2012, 120(8): 1177-1182.
|
| [9] |
Yu T, Liu M, Luo H, et al. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17beta-estradiol in triple-negative breast cancer cells[J]. J Steroid Biochem Mol Biol, 2014, 143: 392-403.
|
| [10] |
Martin SG, Lebot MN, Sukkarn B, et al. Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients[J]. Oncotarget, 2018, 9(40): 25 946-25 956.
|
| [11] |
Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1)：W98-102.
|
| [12] |
Gyorffy B, Lanczky A, Eklund AC, et al. An online survival analysis tool to rapidly assess the effect of 22，277 genes on breast cancer prognosis using microarray data of 1809 patients[J]. Breast Cancer Res Treat, 2010，123(3)：725-731.
|
| [13] |
Filardo EJ, Quinn JA, Bland KI, et al, Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF[J]. Mol Endocrinol, 2000, 14(10): 1649-1660.
|
| [14] |
Ignatov T, Modl S, Thulig M, et al. GPER-1 acts as a tumor suppressor in ovarian cancer[J]. J Ovarian Res, 2013, 6(1): 51.
|
| [15] |
Tsai CL, Wu HM, Lin CY, et al. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor alpha (ERalpha) [J]. PLoS One, 2013, 8(9): e72999.
|
| [16] |
Poola I, Abrham J, Liu A, et al. The cell surface estrogen receptor, G protein-coupled receptor 30 (GPR30), is markedly down regulated during breast tumorigenesis[J]. Breast Cancer (Auckl), 2008，1: 65-78.
|
| [17] |
Pandey DP, Lappano R, Albanito L, et al. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF[J]. EMBO J, 2009, 28(5): 523-532.
|
| [18] |
Li Y, Chen Y, Zhu ZX, et al. 4-hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells[J]. Toxicology, 2013，309: 61-65.
|
| [19] |
Pupo M, Pisano A, Abonante S, et al. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs) [J]. Int J Biochem Cell Biol, 2014，46: 56-67.
|
| [20] |
Jiang QF, Wu TT, Yang JY, et al. 17beta-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1[J]. J Steroid Biochem Mol Biol, 2013, 138: 314-324.
|
| [21] |
Mo Z, Liu M, Yang F, et al. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer[J]. Breast Cancer Res, 2013，15(6): R114.
|
| [22] |
郭林英，余腾骅，张光君，等. 肿瘤相关成纤维细胞中GPER介导HMGB1外分泌促进乳腺癌MCF-7细胞自噬及增殖[J]．肿瘤， 2017, 37(5)：448-456.
|
| [23] |
余腾骅，涂刚，彭美茜，等. 肿瘤相关成纤维细胞中G蛋白偶联雌激素受体胞浆转位介导的旁分泌对乳腺癌细胞生长的影响[J]．中国普通外科杂志， 2019，28(5)：573-580.
|
| [24] |
Santolla MF, Vivacqua A, Lappano R, et al. GPER mediates a feedforward FGF2/FGFR1 paracrine activation coupling CAFs to cancer cells toward breast tumor progression[J]. Cells, 2019，8(3): E223.
|
| [25] |
Weißenborn C, Ignatov T, Poehlmann A, et al, GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells[J]. J Cancer Res Clin Oncol, 2014, 140(4): 663-671.
|
| [26] |
Ignatov A, Ignatov T, Weissenborn C, et al. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer[J]. Breast Cancer Res Treat, 2011, 128(2)：457-466.
|
| [27] |
Sjöström M, Hartman L, Grabau D, et al. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer[J]. Breast Cancer Res Treat, 2014，145(1)：61-71.
|
| [28] |
Broselid S, Cheng B, Sjöström M, et al. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients[J]. Clin Cancer Res, 2013，19(7): 1681-1692.
|